Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting-Reference-Cited by-同舟云学术

Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting

Published:2015-02-02 Issue:7 Volume:35 Page:1845-1852
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Höner zu Siederdissen Christoph¹,Maasoumy Benjamin¹,Deterding Katja¹,Port Kerstin¹,Sollik Lisa¹,Mix Carola¹,Kirschner Janina¹,Cornberg Janet¹,Manns Michael P.¹,Wedemeyer Heiner¹,Cornberg Markus¹

Affiliation:

1. Department for Gastroenterology; Hepatology and Endocrinology; Hannover Medical School; Hannover Germany

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12774/fullpdf

Reference26 articles.

1. Global epidemiology and genotype distribution of the hepatitis C virus;Gower;J Hepatol,2014

2. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890;Hézode;J Hepatol,2013

3. Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting;Maasoumy;PLoS ONE,2013

4. Sofosbuvir for previously untreated chronic hepatitis C infection;Lawitz;N Engl J Med,2013

5. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options;Jacobson;N Engl J Med,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequency of Potential Drug–Drug Interactions in the Changing Field of HCV Therapy;Open Forum Infectious Diseases;2020-02-01

2. Utility of viral kinetics in HCV therapy – It is not over until it is over?;Liver International;2019-04-25

3. Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals: results from the German Hepatitis C-Registry;European Journal of Gastroenterology & Hepatology;2019-02

4. Treatment of Chronic Hepatitis C: Efficacy, Side Effects and Complications;Visceral Medicine;2019

5. Safety, Tolerability, and Associated Side Effects of Direct- Acting Antivirals;Hepatitis C - From Infection to Cure;2018-10-10